Progressive hyperglycemia across the glucose tolerance continuum in older obese adults is related to skeletal muscle capillarization and nitric oxide bioavailability

Thomas P J Solomon, Jacob M Haus, Yanjun Li, John P Kirwan, Thomas P J Solomon, Jacob M Haus, Yanjun Li, John P Kirwan

Abstract

Context: Reduced tissue nutrient exposure may aid in the progression of glucose intolerance.

Objective: The aim of the study was to examine peripheral tissue glucose disposal in relation to muscle capillarization and plasma nitric oxide bioavailability.

Design: Participants were carefully matched for age, adiposity, and lipid status and stratified into normal (n = 20), impaired (n = 20), and type 2 diabetic (n = 20) glucose-tolerant groups.

Setting: The study was conducted in an outpatient setting at a Clinical Research Unit.

Participants: Older, obese men and women (n = 60; age, 65 ± 1 yr; body mass index, 32.7 ± 0.5 kg/m(2)) participated in the study.

Intervention: We performed a cross-sectional study.

Main outcome measures: Body composition, energy metabolism, aerobic fitness (maximum oxygen consumption), insulin sensitivity (glucose clamp), vastus lateralis muscle morphology, and plasma nitric oxide were assessed.

Results: Although subjects were identical with respect to age, body composition, energy expenditure, and lipid status, insulin-stimulated glucose disposal and maximum oxygen consumption showed progressive decline with increasing glucose intolerance. Muscle fiber type composition and mitochondrial density were not different between groups. However, capillary density markedly declined with advancing glucose intolerance (1.86 ± 0.31, 1.70 ± 0.28, 1.42 ± 0.24 capillary/fiber; P < 0.05), a trend that was mirrored by fasting plasma nitric oxide concentrations (26.3 ± 3.6, 19.8 ± 2.3, 15.2 ± 2.1 μmol/liter; P < 0.05). Furthermore, skeletal muscle capillary density correlated with insulin sensitivity (r = 0.65; P < 0.001).

Conclusions: Impaired muscle capillarization and reduced nutrient exposure to the metabolizing tissue may play a major role in the progression of insulin resistance across the glucose tolerance continuum, independent of age, adiposity, lipid status, and resting energy metabolism. These data also highlight plasma nitric oxide as a potential surrogate marker of these impairments and may be indicative of the progression toward type 2 diabetes.

Figures

Fig. 1.
Fig. 1.
Representative photomicrographs of skeletal muscle morphology. Vastus lateralis skeletal muscle biopsies were obtained, and histomounts were stained using an amylase-periodic acid Schiff histochemical stain (A), and an ATPase histochemical stain (B). I, Type I muscle fibers; II, type 2 muscle fibers. Blue staining indicates nuclei; purple staining indicates capillaries. The inset bar represents 50 μm.
Fig. 2.
Fig. 2.
Progressive reduction in plasma nitric oxide levels across the glucose tolerance continuum. Older, obese men and women were divided into three age-, BMI-, adiposity-, and lipid status-matched groups according to their state of glucose tolerance: normal glucose tolerance (Obese-NGT; n = 20), impaired glucose tolerance (Obese-IGT; n = 20), and T2DM (Obese-T2DM; n = 20). Plasma nitrite/nitrate concentrations, a marker of nitric oxide production (NOx), were measured in the basal (A) and insulin-stimulated (B) states. NOx levels were also progressively decreased with advancing glucose intolerance but unresponsive to hyperinsulinemia in each group. Significant differences between means were identified by one-way ANOVA (*, P < 0.05).
Fig. 3.
Fig. 3.
The relationship between insulin sensitivity and skeletal muscle capillary density. Skeletal muscle histochemical procedures were performed in 40 individuals (16 Obese-NGT, 15 Obese-IGT, and nine Obese-T2DM). Regression analyses revealed that insulin-stimulated glucose disposal (GDR, mg/kg · min) was significantly related to skeletal muscle capillary density (CD, mm−2; r = 0.65; P < 0.001).

References

    1. Defronzo RA. 2009. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58:773–795
    1. Shulman GI. 2000. Cellular mechanisms of insulin resistance. J Clin Invest 106:171–176
    1. Clark MG, Barrett EJ, Wallis MG, Vincent MA, Rattigan S. 2002. The microvasculature in insulin resistance and type 2 diabetes. Semin Vasc Med 2:21–31
    1. Laakso M, Edelman SV, Brechtel G, Baron AD. 1990. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest 85:1844–1852
    1. Clerk LH, Vincent MA, Jahn LA, Liu Z, Lindner JR, Barrett EJ. 2006. Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle. Diabetes 55:1436–1442
    1. Slimani L, Oikonen V, Hällsten K, Savisto N, Knuuti J, Nuutila P, Iozzo P. 2006. Exercise restores skeletal muscle glucose delivery but not insulin-mediated glucose transport and phosphorylation in obese subjects. J Clin Endocrinol Metab 91:3394–3403
    1. Clerk LH, Vincent MA, Barrett EJ, Lankford MF, Lindner JR. 2007. Skeletal muscle capillary responses to insulin are abnormal in late-stage diabetes and are restored by angiotensin-converting enzyme inhibition. Am J Physiol Endocrinol Metab 293:E1804–E1809
    1. Gudbjörnsdóttir S, Sjöstrand M, Strindberg L, Lönnroth P. 2005. Decreased muscle capillary permeability surface area in type 2 diabetic subjects. J Clin Endocrinol Metab 90:1078–1082
    1. Moncada S, Higgs A. 1993. The L-arginine-nitric oxide pathway. N Engl J Med 329:2002–2012
    1. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. 1999. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399:601–605
    1. Tsukahara H, Kikuchi K, Tsumura K, Kimura K, Hata I, Hiraoka M, Sudo M. 1997. Experimentally induced acute hyperinsulinemia stimulates endogenous nitric oxide production in humans: detection using urinary NO2-/NO3-excretion. Metabolism 46:406–409
    1. Piatti PM, Monti LD, Valsecchi G, Conti M, Nasser R, Guazzini B, Fochesato E, Phan CV, Pontiroli AE, Pozza G. 1996. Effects of low-dose heparin infusion on arterial endothelin-1 release in humans. Circulation 94:2703–2707
    1. Kashyap SR, Roman LJ, Lamont J, Masters BS, Bajaj M, Suraamornkul S, Belfort R, Berria R, Kellogg DL, Jr, Liu Y, DeFronzo RA. 2005. Insulin resistance is associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects. J Clin Endocrinol Metab 90:1100–1105
    1. Bradley SJ, Kingwell BA, Canny BJ, McConell GK. 2007. Skeletal muscle neuronal nitric oxide synthase micro protein is reduced in people with impaired glucose homeostasis and is not normalized by exercise training. Metabolism 56:1405–1411
    1. American Diabetes Association 2010. Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1):S62–S69
    1. Brooks GA, Butte NF, Rand WM, Flatt JP, Caballero B. 2004. Chronicle of the Institute of Medicine physical activity recommendation: how a physical activity recommendation came to be among dietary recommendations. Am J Clin Nutr 79:921S–930S
    1. Solomon TP, Haus JM, Kelly KR, Cook MD, Riccardi M, Rocco M, Kashyap SR, Barkoukis H, Kirwan JP. 2009. Randomized trial on the effects of a 7-d low-glycemic diet and exercise intervention on insulin resistance in older obese humans. Am J Clin Nutr 90:1222–1229
    1. O'Leary VB, Marchetti CM, Krishnan RK, Stetzer BP, Gonzalez F, Kirwan JP. 2006. Exercise-induced reversal of insulin resistance in obese elderly is associated with reduced visceral fat. J Appl Physiol 100:1584–1589
    1. Frayn KN. 1983. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55:628–634
    1. DeFronzo RA, Tobin JD, Andres R. 1979. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223
    1. Solomon TP, Sistrun SN, Krishnan RK, Del Aguila LF, Marchetti CM, O'Carroll SM, O'Leary VB, Kirwan JP. 2008. Exercise and diet enhance fat oxidation and reduce insulin resistance in older obese adults. J Appl Physiol 104:1313–1319
    1. Wennmalm A, Benthin G, Edlund A, Jungersten L, Kieler-Jensen N, Lundin S, Westfelt UN, Petersson AS, Waagstein F. 1993. Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ Res 73:1121–1127
    1. Brooke MH, Kaiser KK. 1970. Three “myosin adenosine triphosphatase” systems: the nature of their pH lability and sulfhydryl dependence. J Histochem Cytochem 18:670–672
    1. Andersen P. 1975. Capillary density in skeletal muscle of man. Acta Physiol Scand 95:203–205
    1. Shaw CS, Jones DA, Wagenmakers AJ. 2008. Network distribution of mitochondria and lipid droplets in human muscle fibres. Histochem Cell Biol 129:65–72
    1. Liu Z, Liu J, Jahn LA, Fowler DE, Barrett EJ. 2009. Infusing lipid raises plasma free fatty acids and induces insulin resistance in muscle microvasculature. J Clin Endocrinol Metab 94:3543–3549
    1. Terjung RL, Zarzeczny R, Yang HT. 2002. Muscle blood flow and mitochondrial function: influence of aging. Int J Sport Nutr Exerc Metab 12:368–378
    1. Gavin TP, Stallings HW, 3rd, Zwetsloot KA, Westerkamp LM, Ryan NA, Moore RA, Pofahl WE, Hickner RC. 2005. Lower capillary density but no difference in VEGF expression in obese vs. lean young skeletal muscle in humans. J Appl Physiol 98:315–321
    1. Tack CJ, Ong MK, Lutterman JA, Smits P. 1998. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone. Diabetologia 41:569–576
    1. Westerbacka J, Vehkavaara S, Bergholm R, Wilkinson I, Cockcroft J, Yki-Järvinen H. 1999. Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity. Diabetes 48:821–827
    1. de Jongh RT, Serné EH, IJzerman RG, de Vries G, Stehouwer CD. 2004. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation 109:2529–2535
    1. Vincent MA, Barrett EJ, Lindner JR, Clark MG, Rattigan S. 2003. Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. Am J Physiol Endocrinol Metab 285:E123–E129
    1. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. 1994. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 94:1172–1179
    1. Keske MA, Clerk LH, Price WJ, Jahn LA, Barrett EJ. 2009. Obesity blunts microvascular recruitment in human forearm muscle after a mixed meal. Diabetes Care 32:1672–1677
    1. Weiss EP, Park JJ, McKenzie JA, Park JY, Kulaputana O, Brown MD, Phares DA, Hagberg JM. 2004. Plasma nitrate/nitrite response to an oral glucose load and the effect of endurance training. Metabolism 53:673–679
    1. Qu Z, Andersen JL, Zhou S. 1997. Visualisation of capillaries in human skeletal muscle. Histochem Cell Biol 107:169–174
    1. Yago MD, Mañas M, Ember Z, Singh J. 2001. Nitric oxide and the pancreas: morphological base and role in the control of the exocrine pancreatic secretion. Mol Cell Biochem 219:107–120
    1. Newsholme P, Homem De Bittencourt PI, O' Hagan C, De Vito G, Murphy C, Krause MS. 2010. Exercise and possible molecular mechanisms of protection from vascular disease and diabetes: the central role of ROS and nitric oxide. Clin Sci (Lond) 118:341–349
    1. Mogensen M, Sahlin K, Fernström M, Glintborg D, Vind BF, Beck-Nielsen H, Højlund K. 2007. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 56:1592–1599
    1. Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsøe R, Dela F. 2007. Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 50:790–796

Source: PubMed

3
Sottoscrivi